C07D 243/34
Containing a quinazoline or hydrogenated quinazoline ring system
Official title: containing a quinazoline or hydrogenated quinazoline ring system
C07D243/34 (Containing a quinazoline or hydrogenated quinazoline ring system) appears on 5 US grants and 5 published applications in this corpus.
Search patents in C07D- Granted patents
- 5
- Published applications
- 5
- Assignees
- 3
- Inventors
- 11
- Latest grant
- 27 Jun 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 1 | 1 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
By publication year.
Recent patents
- Combinations of copanlisib with anti-PD-1 antibody27 Jun 2023US 11,684,672 B2Bayer Pharma Aktiengesellschaft
- Isoprenyl compounds and methods thereof11 Jun 2019US 10,314,802 B2Signum Biosciences, Inc.
- Isoprenyl compounds and methods thereof29 Aug 2017US 9,744,147 B2Signum Biosciences, Inc.
- Isoprenyl compounds28 Jun 2016US 9,376,383 B2Signum Biosciences, Inc.
- Isoprenyl compounds and methods thereof12 Feb 2013US 8,372,884 B2Signum Biosciences, Inc.
- Combinations of copanlisib with anti-pd-1 antibody16 Apr 2020US 2020/0114001 A1Bayer Pharma Aktiengesellschaft
- Isoprenyl compounds and methods thereof28 Dec 2017US 2017/0368011 A1Signum Biosciences, Inc.
- Isoprenyl Compounds and Methods Thereof15 Dec 2016US 2016/0361283 A1Signum Biosciences, Inc.
- Isoprenyl compounds and methods thereof21 Nov 2013US 2013/0310559 A1Signum Biosciences, Inc.
- Isoprenyl Compounds and Methods Thereof22 Jul 2010US 2010/0184768 A1Signum Biosciences, Inc.
Most cited
By later US patents